StockGlow

Everest Medicines Limited (6HN.F)

Everest Medicines Limited, a biopharmaceutical company, engages in the discovery, license-in, development, and commercialization of therapies and vaccines to address critical unmet medical needs in Greater China and other Asia Pacific markets.

2.70+0.02%Healthcare
Compare 6HN.F with
StockGlow Score
5
Bearish
BearishBullish
1 year ago-60.3%

The outlook

Everest Medicines Limited currently reads as bearish based on below its 50- & 200-day averages, 4% of the way from its 52-week low to high. This is a snapshot of current market data, not a forecast.

What’s behind the score

Price trendBelow its 50- & 200-day averages
52-week range4% of the way from its 52-week low to high
Market cap
$948.6M
52-wk high
7.90
52-wk low
2.48
50-day avg
2.90
200-day avg
3.95
Trailing P/E
—

Similar stocks

7O2.SGOM Holdings Limited$0.00+0.00%722.FAntengene Corporation Limited$0.41+0.98%9O8.FEnerside Energy, S.A.$0.36-0.55%2VJ.SGAscletis Pharma Inc.$0.91-3.19%0QNZ.LCPH Group AG$58.00+0.69%

The StockGlow Score is a snapshot of current, observable market data (analyst ratings, price trend, 52-week range) — not a prediction, forecast, or recommendation. Informational only, not investment advice. Data from public sources and may be delayed. How this works·Privacy